Form 144 Dyne Therapeutics, Inc. Filed by: Cox John
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Stifel on Dyne Therapeutics Inc. (DYN): 'Longer-term Data At MDA Support DYNE-251's Strong DMD Profile'
March 9, 2026 10:29 AM EDTStifel on Dyne Therapeutics Inc. (NASDAQ: DYN): 'Longer-term Data At MDA Support DYNE-251's Strong DMD Profile'.
The analyst comments "We're reiterating our Buy-Rating on DYN following their updates at the 2026 MDA conference, where they unveiled the design of their ph3 confirmatory... More
